Morphological Screening of Mesenchymal Mammary Tumor Organoids to Identify Drugs That Reverse Epithelial-Mesenchymal Transition

Scientists reported that cells derived from claudin-low mammary tumors, a mesenchymal subtype of triple-negative breast cancer, exhibited a distinctive organoid structure with extended “spikes” in 3D matrices.